Orthopedic Biomaterial Market Research- Asia Pacific Forecast Till 2030

Asia Pacific Orthopedic Biomaterial Market Information, By Type Of Material (Metal, Non-Metal), By Application (Joint Replacement, Fracture Fixation Devices, Tissue Fixation, Spine Implants Viscosupplementation, And Others), And By End Users (Hospital, Clinics) - Forecast Till 2030

ID: MRFR/MED/0200-HCR | December 2022 | Region: Asia-Pacific | 50 Pages         

Asia Pacific Orthopedic Biomaterial Market Scenario

The Orthopedic Biomaterial Market is expected to reach USD
40,519.52 million by 2030 at 10.5% CAGR during the forecast period 2022-2030. Orthopedic biomaterials are organic or synthetic materials used for the treatment of internal fractures. During the last decade different new techniques and materials are introduced for orthopedic implants and surgeries and biomaterials have found a vital role in it. These biomaterials are used in manufacturing of different implants since they do not evoke any immunological reactions with the body, which makes it a first choice for manufacturing of implants. Increasing demand for the orthopedic biomaterial because of its application in knee and hip replacement surgeries, and increasing incident of medical emergencies drive the Asia Pacific orthopedic biomaterial market. Introduction of novel implants of titanium has increased the success rate of implant surgeries and also contributed to the growth of the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries, increasing aging population, and growing governmental support also drive the Asia Pacific market. However, increasing failure in joints implants, stringent regulatory laws, and high cost of treatment may hinder the growth of Asia Pacific orthopedic biomaterial market during the review period.


Figure 1- Asia Pacific orthopedic biomaterial market, by application Asia Pacific Orthopedic Biometrial Market

  Sources: Annual reports, Press release, White paper, Company Presentation

Key Players

Some of the major players in Asia Pacific orthopedic biomaterial market: Kyocera Corporation (Japan), Materion Corporation (US), S&V Technologies (Germany), Rayner (UK), InVision Biomedical (US), Covestro (Germany), Invibio Ltd. (U.K.), Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), CeramTec (Germany), Tianjin Walkman Biomaterial Co. (China), Kanghui Holdings (China), Johnson & Johnson Services, Inc. (US), Cam Bioceramics B.V. (Netherland), and Xian Airfoil Technology Co (China).


The orthopedic biomaterials market is segmented on the basis of types of material, applications, and end users. On the basis of types of material, the market is segmented into metals and non-metals.  The metals are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric, natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester, and other. The natural biomaterials are sub-segmented into collagen, chitin & chitosan, and other

On the basis of applications, the Asia Pacific orthopedic biomaterial market is segmented into joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and other. Joint replacement is sub-segmented into hip replacement, knee replacement, shoulder and elbow replacement, and other. Tissue fixation is sub-segmented into interference screws, suture anchors, and others. Spine implants are further sub-segmented into spine fusion and other. The fracture fixation devices are sub segmented into screws, plates for bones, rods, and other.

On the basis of end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.

Market Assessment Asia Pacific Orthopedic Biometrial Market-

Sources: Annual reports, World Health Organization (WHO), White paper, Company Presentation, International Osteoporosis Foundation

Regional Analysis

China dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the Asia Pacific orthopedic biomaterial market in this region. 

Intended Audience

  • Product manufacturers

  • Biomaterial manufacturer

  • Research and development (R&D) companies

  • Hospitals and laboratories

  • Medical research laboratories

  • Academic medical institutes and universities

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 40,519.52 million
  CAGR   10.5%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product Type, Material Class
  Geographies Covered   North America, Europe, Asia Pacific
  Key Vendors   Stryker (US) CoorsTek Inc. (US) Zimmer Biomet Holdings Inc. (US) Institut Straumann AG (Switzerland) Kyocera Corporation (Japan) Smith & Nephew plc (UK) 3M (US) Nobel Biocare Services AG(Switzerland) Medtronicplc (Ireland) DePuy Synthes (US)
  Key Market Opportunities   Technological advancement in the medical implants market
  Key Market Drivers   Increasing older population leading to an increase in the patient population

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The Asia Pacific Orthopedic Biomaterial Market CAGR would be 10.5% during the forecast period (2022-2030).

End users in the Asia Pacific Orthopedic Biomaterial Market are hospitals, clinics, and others.

China would dominate the Asia Pacific Orthopedic Biomaterial Market.

The applications of the Asia Pacific Orthopedic Biomaterial Market are viscosupplementation, fracture fixation devices, joint replacement, spine implants, tissue fixation, and other

Players involved are Materion Corporation (US), Kyocera Corporation (Japan), InVision Biomedical (US), S&V Technologies (Germany), Rayner (UK), Invibio Ltd. (U.K.), Royal DSM (Netherlands), Covestro (Germany), Corbion N.V. (Netherlands), BASF SE (Germany), Tianjin Walkman Biomaterial Co. (China), CeramTec (Germany), Cam Bioceramics B.V. (Netherland), Johnson & Johnson Services, Inc. (US), Kanghui Holdings (China), and Xian Airfoil Technology Co (China).